Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence

NCT: NCT07270692 · SUSPENDED

NCT IDNCT07270692
StatusSUSPENDED
Start Date2025-08-01
Completion2026-11-01
SponsorEko Devices, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The main objectives of this study are to train and evaluate an algorithm that predicts whether an individual has an ejection fraction ≤ 40%, using heart sounds and a 3-lead ECG as inputs, as well as determine the impact of gender, age, and race on algorithm performance.

Frequently Asked Questions

What is Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence?

Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence is a clinical trial registered under NCT07270692. Current status: SUSPENDED.

What is the status of NCT07270692?

The current status of NCT07270692 (Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence) is: SUSPENDED.

When did Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence start?

Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence started on 2025-08-01.

Related Devices

K170874Eko Model E5 System (EME5), Eko DUOEko Devices, Inc. K192004Eko Analysis SoftwareEko Devices, Inc. K200776Eko COREEko Devices, Inc. K213794Eko Murmur Analysis Software (EMAS)Eko Devices, Inc. K230111CORE 500 Digital StethoscopeEko Devices, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑